Inactive Instrument

News Arena Pharmaceuticals

Equities

ARNA

US0400476075

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Longboard Pharmaceuticals, Inc. and Arena Pharmaceuticals, Inc. Executes into Second Amendment to That Certain License Agreement	22-09-19	CI
Biopharma Stocks Targeting Crohn's Disease In $13.7 Billion Market (STAB, ARNA, GILD and RDHL)	22-03-16	AQ
Arena Pharmaceuticals, Inc.(NasdaqGS:ARNA) dropped from S&P Biotechnology Select Industry Index	22-03-15	CI
Arena Pharmaceuticals, Inc.(NasdaqGS:ARNA) dropped from S&P TMI Index	22-03-15	CI
Arena Pharmaceuticals, Inc.(NasdaqGS:ARNA) dropped from S&P Global BMI Index	22-03-15	CI
Pfizer Completes Acquisition of Arena Pharmaceuticals	22-03-14	AQ
Pfizer Completes $6.7 Billion Acquisition of Arena Pharmaceuticals	22-03-11	MT
Arena Pharmaceuticals : Completion of Acquisition or Disposition of Assets - Form 8-K	22-03-11	PU
ARENA PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	22-03-11	AQ
Arena Pharmaceuticals, Inc. Announces Board Changes	22-03-11	CI
Arena Pharmaceuticals, Inc.(NasdaqGS:ARNA) dropped from NASDAQ Biotechnology Index	22-03-11	CI
Arena Pharmaceuticals, Inc.(NasdaqGS:ARNA) dropped from NASDAQ Composite Index	22-03-11	CI
Pfizer Inc. completed the acquisition of Arena Pharmaceuticals, Inc..	22-03-10	CI
ARENA PHARMACEUTICALS INC : Other Events (form 8-K)	22-03-10	AQ
ARENA PHARMACEUTICALS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	22-02-23	AQ
Arena Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-23	CI
Arena Pharmaceuticals Extends Q4 Loss, Reports Higher Revenue	22-02-23	MT
Arena Pharmaceuticals : Reports Fourth Quarter and Full Year 2021 Financial Results and Key Program Updates - Form 8-K	22-02-23	PU
Earnings Flash (ARNA) ARENA PHARMACEUTICALS Reports Q4 Revenue $54,000, vs. Street Est of $0.732M	22-02-23	MT
Earnings Flash (ARNA) ARENA PHARMACEUTICALS Reports Q4 Loss $-2.54, vs. Street Est of $-2.23	22-02-23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Arena Pharmaceuticals

Equities

ARNA

US0400476075

Summary

Filters